Advances in clinical diagnosis of secondary progressive multiple sclerosis

Advances in clinical diagnosis of secondary progressive multiple sclerosis

Multiple sclerosis(MS) is a chronic inflammatory disease of the central nervous system that involves demyelination and axonal degeneration. Usually, MS begins with a relapsing-remitting MS (RRMS) course, and approxi mately will develop into secondary progressive multiple sclerosis (SPMS). At present...

Full description

Bibliographic Details
Main Author:	ZHANG Chao, GAO Xue
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Diagnostics Concepts & Practice 2022-12-01
Series:	Zhenduanxue lilun yu shijian
Subjects:	\|secondary progressive multiple sclerosis\|pathogenesis\|clinical diagnosis\|leptomeningeal follicle-like structure
Online Access:	https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1682220141446-1482475068.pdf

Similar Items

New possibilities for the therapy of secondary progressive multiple sclerosis
by: A. M. Petrov, et al.
Published: (2019-12-01)

The first cases of using targeted therapy for secondary progressive multiple sclerosis in Russia. Case report
by: Denis S. Korobko, et al.
Published: (2023-05-01)

Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis
by: Ya. V. Vlasov, et al.
Published: (2021-09-01)

New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis
by: D. S. Kasatkin, et al.
Published: (2021-02-01)

Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»
by: N. V. Khachanova, et al.
Published: (2019-12-01)

The Role of B Cells in Primary Progressive Multiple Sclerosis
by: Jameson P. Holloman, et al.
Published: (2021-06-01)

Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype
by: Bruno Brochet, et al.
Published: (2022-01-01)

Consensus on early detection of disease progression in patients with multiple sclerosis
by: José E. Meca-Lallana, et al.
Published: (2022-07-01)

Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil
by: Vijayalakshmi Vasanthaprasad, et al.
Published: (2022-08-01)

Should We Use Clinical Tools to Identify Disease Progression?
by: Hernan Inojosa, et al.
Published: (2021-01-01)

Editorial: Measuring progression in Multiple Sclerosis: Progressing beyond the ordinary
by: Carynn Koch, et al.
Published: (2022-11-01)

Changes in retinal structures as markers of multiple sclerosis progression
by: M. O. Poplyak, et al.
Published: (2021-12-01)

Consensus for the Early Identification of Secondary Progressive Multiple Sclerosis in Portugal: a Delphi Panel
by: Maria José Sá, et al.
Published: (2023-02-01)

Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence
by: Sabsabi S, et al.
Published: (2022-05-01)

Effect of Rituximab on the cognitive impairment in patients with secondary progressive multiple sclerosis
by: Saeideh Salehizadeh, et al.
Published: (2022-06-01)

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
by: Vermersch Patrick, et al.
Published: (2012-06-01)

Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021
by: Crystal Watson, et al.
Published: (2023-09-01)

Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis
by: Smaranda Maier, et al.
Published: (2023-02-01)

Proteomics in Multiple Sclerosis: The Perspective of the Clinician
by: Dániel Sandi, et al.
Published: (2022-05-01)

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics
by: Emily Kamma, et al.
Published: (2022-02-01)

Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study
by: Ambra Mara Giovannetti, et al.
Published: (2020-08-01)

Novel Drugs in a Pipeline for Progressive Multiple Sclerosis
by: Klaudia Sapko, et al.
Published: (2022-06-01)

Deciphering Multiple Sclerosis Progression
by: Virginia Meca-Lallana, et al.
Published: (2021-04-01)

Comparing power and activity of lower body muscles in two types of multiple sclerosis patients and healthy individuals
by: Talebi V, et al.
Published: (2020-05-01)

Long-Term Disability Outcomes in Relapsing–Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression
by: Laura Barcutean, et al.
Published: (2024-03-01)

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
by: Sylwia Pietrasik, et al.
Published: (2021-11-01)

Rehabilitation treatment of multiple sclerosis
by: Haoyang Duan, et al.
Published: (2023-04-01)

Primary progressive multiple sclerosis in the Polish population
by: Waldemar Brola, et al.
Published: (2017-03-01)

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany
by: Alessandra Solari, et al.
Published: (2019-08-01)

Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
by: Liesa Regner-Nelke, et al.
Published: (2022-11-01)

The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis
by: Mostafa Almasi, et al.
Published: (2021-01-01)

In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple Sclerosis
by: Marco Calabrò, et al.
Published: (2024-03-01)

Clinical markers for unfavorable course of multiple sclerosis
by: Mariya S. Matrosova, et al.
Published: (2023-09-01)

Mitoxantrone in the treatment of multiple sclerosis: a single-center experience
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-06-01)

Multiple sclerosis: current state
by: A. V. Peresedova, et al.
Published: (2017-02-01)

Rehabilitation of patients with progressive forms of multiple sclerosis
by: S. A. Sivertseva, et al.
Published: (2022-08-01)

The early diagnosis and treatments in multiple sclerosis
by: So Young Huh
Published: (2017-12-01)

OCRELIZUMAB IN THE TREATMENT OF PRIMARY-PROGRESSIVE MULTIPLE SCLEROSIS
by: E. V. Popova
Published: (2018-02-01)

Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date
by: Gajofatto A
Published: (2017-11-01)

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis
by: Carmen Alcalá Vicente, et al.
Published: (2022-10-01)